Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, Sept. 07, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Molecular Partners AG (“Molecular Partners” or “the Company”) (NASDAQ: MOLN) investors that a class action has been filed on behalf of investors. Molecular Partners investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
According to the Complaint, the Company made false and misleading statements to the market. Molecular Partners’ ensovibep was not as effective at treating COVID-19 as the Company had stated. The FDA was likely to require an additional Phase 3 study before granting the drug a EUA. The decreasing rate of COVID-19 globally diminished the likelihood of the FDA granting a EUA to the Company. The Company’s product candidate MP0310 was of less interest to Amgen than it led the market to believe. There was a significant chance that Amgen would return global rights to the product candidate back to the Company. Based on these facts, the Company’s public statements were false and materially misleading throughout the IPO and class period. When the market learned the truth about Molecular Partners, investors suffered damages.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com
Attorney Advertising
